CD40LG Gene

Last updated on: 08.06.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

CD40LG (CD40 ligand) is a protein-coding gene located on chromosome Xq26.3. The CD40 ligand encoded by the CD40LG gene on the X chromosome is expressed on the surface of T cells (Zhou Y et al. 2009). The CD40 ligand stimulates T cell proliferation and cytokine production . Its cross-linking on T cells generates a costimulatory signal that increases the production of IL4 and IL10 in conjunction with TCR/CD3 ligation and CD28 costimulation. CD40LG induces NF-kappa-B activation and MAPK8 and PAK2 kinase activation in T cells. Furthermore, CD40LG induces tyrosine phosphorylation of isoform 3 of CD28, mediating proliferation of B cells in the absence of a co-stimulus and IgE production in the presence of IL4. The ligand is involved in the switching of immunoglobulin classes.

General informationThis section has been translated automatically.

CD40 ligand acts as a ligand for integrins, specifically ITGA5:ITGB1 and ITGAV:ITGB3; both integrins and the CD40 receptor are required for activation of CD40-CD40LG signaling, which has cell type-dependent effects, such as B-cell activation, NF-kappa-B signaling, and anti-apoptotic signaling.

A defect in this gene results in an inability to undergo immunoglobulin class switching.

Diseases associated with CD40LG include:

  • "CD40 ligand deficiency".

Note: CD40 ligand (CD40LG) is overexpressed on lupus T cells (Zhou Y et al 2009).

LiteratureThis section has been translated automatically.

  1. Allen RC et al (1993) CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259: 990-993.
  2. Andre P et al (2002) CD40L stabilizes arterial thrombi by a beta(3) integrin-dependent mechanism. Nature Med. 8: 247-252.
  3. Aruffo A et al (1993) The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72: 291-300.
  4. Aschermann Z et al (2007) X-linked hyper-IgM syndrome associated with a rapid course of multifocal leukoencephalopathy. Arch. Neurol. 64: 273-276.
  5. Hasegawa S et al (2014) Whole-exome sequence analysis of ataxia telangiectasia-like phenotype. J Neurol. Sci. 340: 86-90.
  6. Kraakman ME et al (1995) Identification of a CD40L gene mutation and genetic counselling in a family with immunodeficiency with hyperimmunoglobulinemia M. Clin Genet 48: 46-48.
  7. van Zelm MC et al. (2014) Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation. J Allergy Clin. Immun 134: 135-144.
  8. Zhou Y et al (2009) T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin Immunol 132:362-370.

Last updated on: 08.06.2022